Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693577012 | Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693579010 | Lidocaine hydrochloride 20 mg/mL cutaneous gel | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Is a | Product containing lidocaine in topical dosage form | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Has active ingredient | Lidocaine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Cutaneous gel | true | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Lidocaine hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Has concentration strength numerator value | 20 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) | Is a | Product containing only lidocaine in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR